Electromed, Inc.: Form 10-Q for the period ended Dec 31, 2022
Filed with the SEC on Feb 14, 2023 and accepted by EDGAR at Feb 14, 2023, 16:10 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-10-01 to 2022-12-31 | $11.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2022-07-01 to 2022-12-31 | $22.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-10-01 to 2022-12-31 | $3.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2022-07-01 to 2022-12-31 | $5.4m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2022-10-01 to 2022-12-31 | $8.7m | us-gaap:GrossProfit |
| Gross profit | 6 months2022-07-01 to 2022-12-31 | $17.0m | us-gaap:GrossProfit |
| Research and development | 3 months2022-10-01 to 2022-12-31 | $154.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2022-07-01 to 2022-12-31 | $452.0k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-10-01 to 2022-12-31 | $7.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2022-07-01 to 2022-12-31 | $15.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-10-01 to 2022-12-31 | $1.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-07-01 to 2022-12-31 | $1.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-10-01 to 2022-12-31 | $304.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-07-01 to 2022-12-31 | $271.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-10-01 to 2022-12-31 | $977.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-07-01 to 2022-12-31 | $1.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-10-01 to 2022-12-31 | $0.11 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2022-07-01 to 2022-12-31 | $0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-10-01 to 2022-12-31 | $0.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2022-07-01 to 2022-12-31 | $0.13 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-10-01 to 2022-12-31 | 8,684,352 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2022-07-01 to 2022-12-31 | 8,685,184 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2022-07-01 to 2022-12-31 | −$330.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-07-01 to 2022-12-31 | $687.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2022-10-01 to 2022-12-31 | $8.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Share repurchases | 6 months2022-07-01 to 2022-12-31 | $153.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-12-31 | $6.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $34.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $41.4m | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $6.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $6.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-12-31 | $35.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000897101-23-000085. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.